mRNA/SOL
Gesamtwert | 28 |
|---|---|
24h Vol | 619,8 $ |
Liquidität | 2.129,8 $ |
Halterungen | 95 |
Audits | |
Alter | 2 Tage |
FDV | 2.015,6 $ |
Marktkap | 2.015,6 $ |
| Adressen | |
|---|---|
| Pool | |
| mRNA | |
| SOL |  |
| Entwickler |
mRNA zu SOL Konverter
Gesamtwert | 28 |
|---|---|
24h Vol | 619,8 $ |
Liquidität | 2.129,8 $ |
Halterungen | 95 |
Audits | |
Alter | 2 Tage |
FDV | 2.015,6 $ |
Marktkap | 2.015,6 $ |
Moderna Inc (mRNA)
Recent discussions on mRNA technology have been fueled by announcements from Oracle CEO Larry Ellison about the potential of AI in designing personalized mRNA vaccines for cancer treatment, sparking both interest and controversy on X. Oracle CEO Larry Ellison discussed at the White House how AI could soon design personalized mRNA vaccines for individuals to combat cancer, highlighting the promise of AI in healthcare. This announcement has led to a mix of reactions on X, with some users expressing skepticism or outright opposition to mRNA vaccines due to past experiences with COVID-19 mRNA vaccines, while others see potential in the technology for personalized medicine. The debate on X reflects broader concerns about the safety, efficacy, and ethical implications of mRNA technology, especially in light of its rapid development and application during the COVID-19 pandemic.
Token-Info aktualisierenmRNA/SOL Kursstatistiken
Der aktuelle Kurs von mRNA (mRNA/SOL) bei PumpSwap beträgt 0,000002016 $, ein Anstieg von -5,6 % in den letzten 24 Stunden. Das 24-Stunden-Handelsvolumen wird mit 619,80 $ angegeben, mit einer Gesamtanzahl von 24 Transaktionen. Die Contract-Adresse von mRNA/SOL ist 8PuiDczBmQuTHtwK4YjtRsViQ74hE2jKZY4ib7wrfxN2, mit einer vollständig verwässerten Bewertung (Fully Diluted Valuation, FDV) von 2.015,63 $ und einem Liquiditätspool von 2.129,82 $.
